Shire appoints Thomas Dittrich as its new chief financial officer and simultaneously he becomes an executive member of the board of directors and a member of the executive committee.
He said: “I look forward to working with the board, the executive committee and the finance organisation as we build upon Shire’s strong fundamentals to drive future growth and shareholder value.”
Prior to joining Shire, Dittrich served as chief financial officer at Sulzer, an industrial engineering and manufacturing company and before this, he was at Amgen as its vice president, finance corporate planning and chief accounting officer.
Susan Kilsby, chairman of the board, Shire, said: “Thomas is a talented global executive who will bring to Shire a broad range of experience from both inside and outside the pharmaceutical industry.
“The board and I look forward to working with him during this transformational time in the company’s history.”
No results were found
Origins creates and delivers patient focused strategy, insights, data and solutions, which guides pharma and biotech companies to improve value...